Sanderling Ventures - aVenture Asset Manager Research
Location
San Mateo, CA, US
Founded
1979
Sanderling Ventures is a venture capital firm focusing on investments in biotechnology, therapeutics, pharmaceuticals, medical devices, and healthcare sectors. The firm primarily operates in the United States and Canada, with typical investment rounds including Series A, B, C, D, and later stages. Sanderling Ventures has a broad investment range, participating in various funding rounds to support the growth and development of innovative healthcare companies.
Notable portfolio companies include Chimerix, Dynavax Technologies, Glycomine, Metavention, and ViaCyte. Key partners and decision-makers at Sanderling Ventures bring extensive industry experience and networks to the table, providing strategic guidance and support to their portfolio companies. The firm’s investment philosophy emphasizes fostering groundbreaking advancements in healthcare through substantial financial backing and value-added services such as mentorship, industry connections, and operational expertise.
Sanderling Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages